Article citationsMore>>

Shin, D.M., Lee, J., Noh, H., Jang, D., Oh, S.J., Park, J.H., et al. (2022) A Double-Blind, Split-Face, Randomized Study on the Effects and Safety of Intradermal Injection of Botulinum Toxin a (Incobotulinum Toxin A) in the Cheek. Annals of Dermatology, 34, 442-450.
https://doi.org/10.5021/ad.21.316

has been cited by the following article:

• TITLE: Prospective Evaluation of Intradermal Botulinum Toxin Type A Microinjections for Sebum Reduction and Acne Improvement in Adults: A Single-Centre Interventional Study

  AUTHORS: Maryna Spivak

  KEYWORDS: Botulinum Toxin Type A, Intradermal Microinjections, Acne Vulgaris, Seborrhoea, Sebum Reduction, Microtoxin, Aesthetic Dermatology

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.14 No.11, October 30, 2026

  ABSTRACT: Sebum overproduction is a key factor in acne vulgaris and seborrhea. This prospective, single-center, interventional study evaluated the efficacy and safety of standardized intradermal microinjections of botulinum toxin type A (BoNT-A) in 42 adults with mild-to-moderate facial acne and seborrhea. Participants received 40 - 60 units of onabotulinumtoxin A via microdroplet technique. Outcomes included sebum levels (Sebumeter), acne lesion counts, patient satisfaction (Visual Analogue Scale [VAS] and Global Aesthetic Improvement Scale [GAIS]), and adverse events. After treatment, sebum production was observed to decrease by 47.9% at 4 weeks and 35.2% at 12 weeks (p